SIRT6 expression was abnormal in various gastrointestinal tumor tissues, including colorectal cancer [10,11,12,13,14], gastric cancer (GC) [15], pancreatic cancer [16,17], and hepatocellular carcinoma (HCC) [18,19]. Here, SIRT6 is linked to gastric cancer.